Mizuho raises Teleflex price target to $145

0 min read     Updated on 16 Jul 2026, 02:45 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Mizuho analyst Anthony Petrone maintained a Neutral rating on Teleflex (NYSE: TFX) and raised the price target to $145 from $140. The adjustment reflects a revised valuation outlook for the medical technology company.

powered bylight_fuzz_icon
45695691

*this image is generated using AI for illustrative purposes only.

Mizuho analyst Anthony Petrone has maintained a Neutral rating on Teleflex (NYSE: TFX) while raising the price target to $145 from the previous $140. The revised target indicates a modest increase in the stock's potential upside based on the firm's latest assessment.

The rating update provides investors with a specific price benchmark for the medical technology company. Teleflex operates in the healthcare sector, specializing in medical devices.

What specific factors drove Mizuho to raise the price target despite maintaining a Neutral rating?

How might Teleflex's recent product launches impact its revenue growth in the upcoming quarters?

What are the potential risks Teleflex faces in the current healthcare regulatory environment?

like19
dislike

BMO Capital initiates coverage on Teleflex with Outperform rating

0 min read     Updated on 09 Jul 2026, 10:33 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

BMO Capital analyst Vik Chopra has initiated coverage on Teleflex with an Outperform rating and announced a price target of $159.

powered bylight_fuzz_icon
45162185

*this image is generated using AI for illustrative purposes only.

BMO Capital analyst Vik Chopra has initiated coverage on Teleflex with an Outperform rating and announced a price target of $159. The rating suggests the stock is expected to perform better than the broader market average.

Analyst Details

The coverage initiation provides a new outlook for Teleflex investors. The price target of $159 indicates the firm's valuation expectations for the company.

Firm Analyst Rating Price Target
BMO Capital Vik Chopra Outperform $159

What specific factors are driving BMO Capital's bullish outlook on Teleflex?

How might Teleflex's upcoming product launches impact its stock performance?

What are the potential risks that could prevent Teleflex from reaching the $159 price target?

like16
dislike

More News on Teleflex Inc